BNTCBENITEC BIOPHARMA INC
CUSIP 08205P209 · common stock
1 tracked investor held BENITEC BIOPHARMA INC (BNTC) at the end of Q3 2026, worth $18.5M. The largest holder was RA Capital Management, with 0.2% of its portfolio. Adar1 Capital Management sold out of its position this quarter.
Holders · Q3 2026
1
New holders
0
Value held
$18.5M
Quarter-end price (est.)
$10.00
Investors holding BNTC · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| RA Capital Management RA Capital Management, L.P. | 0.19% | 1,850,000 | $18.5M | HOLD |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Adar1 Capital Management | 0.02% | 40,000 | $535.2K | EXIT |